|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.05 USD | -2.27% |
|
-5.43% | -6.70% |
| 05-09 | Enfusion Shares Fall Despite Higher Q1 Results | MT |
| 05-09 | Transcript : Enfusion, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Enfusion, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 46.49 million compared to USD 40.52 million a year ago. Net income was USD 0.623 million compared to USD 0.494 million a year ago.
Basic earnings per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. Diluted earnings per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.70% | 832M | |
| +10.29% | 3,082B | |
| +8.12% | 84.92B | |
| +5.55% | 78.23B | |
| -13.73% | 54.06B | |
| -24.43% | 46.79B | |
| +19.98% | 45.87B | |
| +21.26% | 42.65B | |
| +60.27% | 37.28B | |
| -9.36% | 24.89B |
ENFUSION, INC. 